Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.1247 | 0.1247 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0237 | 0.0107 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0237 | 0.01 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Kinase, NEK | 0.0009 | 0 | 0.5 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0864 | 0.4407 | 0.4407 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Ser/Thr protein kinase | 0.0009 | 0 | 0.5 |
Plasmodium vivax | SET domain protein, putative | 0.0036 | 0.0138 | 0.5 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.195 | 1 | 1 |
Echinococcus multilocularis | caspase 2 | 0.0864 | 0.4407 | 0.4329 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0036 | 0.0138 | 0.0007 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0864 | 0.4407 | 0.4407 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.1426 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0237 | 0.0237 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0138 | 0.0138 |
Brugia malayi | Cell death protein 3 precursor | 0.0864 | 0.4407 | 0.4407 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.4999 | 0.4929 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Onchocerca volvulus | Deterin homolog | 0.195 | 1 | 1 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0237 | 0.0237 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.195 | 1 | 1 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0138 | 0.0138 |
Brugia malayi | hypothetical protein | 0.0864 | 0.4407 | 0.4407 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.195 | 1 | 1 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0864 | 0.4407 | 0.4329 |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.195 | 1 | 1 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.0237 | 0.01 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0864 | 0.4407 | 0.4407 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase suv9 | 0.0036 | 0.0138 | 0.0138 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0009 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0237 | 0.0237 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.0864 | 0.4407 | 0.4329 |
Onchocerca volvulus | 0.0286 | 0.1426 | 0.1306 | |
Onchocerca volvulus | 0.0864 | 0.4407 | 0.4329 | |
Echinococcus granulosus | caspase 2 | 0.0864 | 0.4407 | 0.4332 |
Brugia malayi | Pre-SET motif family protein | 0.0036 | 0.0138 | 0.0138 |
Toxoplasma gondii | histone lysine methyltransferase SET/SUV39 | 0.0036 | 0.0138 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.195 | 1 | 1 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.0864 | 0.4407 | 0.4332 |
Loa Loa (eye worm) | hypothetical protein | 0.195 | 1 | 1 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.195 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0237 | 0.0237 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.1247 | 0.1247 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.195 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0237 | 0.0107 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Schistosoma mansoni | histone-lysine n-methyltransferase setb1 | 0.0036 | 0.0138 | 0.0138 |
Onchocerca volvulus | 0.195 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.0138 | 0.0138 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0237 | 0.0237 |
Loa Loa (eye worm) | hypothetical protein | 0.195 | 1 | 1 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.195 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0864 | 0.4407 | 0.4407 |
Giardia lamblia | Protein 21.1 | 0.0009 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.4125 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.5774 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 37.933 uM | PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.